ALFUZOSIN

alfuzosin hydrochloride 10 mg modified release tablet, 30

ALFUZOSIN (14183L)

alfuzosin hydrochloride 10 mg modified release tablet, 30
14183L
Body System:
Manner of administration:Oral
Repatriation Pharmaceutical Benefits
Authority Required

Restriction

Indication: Benign prostatic hyperplasia
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 60 # of repeats: 5 DPMQ: - Max safety net: - General Patient Charge: -
Available brands
Xatral SR DPMQ: $156.70 Max safety net: $7.70 General Patient Charge: $7.70